Literature DB >> 1673835

Endotoxin-tobramycin additive toxicity on renal proximal tubular cells in culture.

V Joly1, Y Bergeron, M G Bergeron, C Carbon.   

Abstract

Aminoglycoside-induced renal damage is enhanced in animals with Escherichia coli pyelonephritis. Bacterial endotoxin is liberated during antibiotic therapy. The toxic effect of endotoxin and tobramycin, alone or in combination, was investigated in primary cultures of rabbit proximal tubular cells grown to confluence in serum-free medium. Sodium-dependent uptakes of Pi and alpha-methylglucopyranoside (MGP) and enzymatic activities (lactate dehydrogenase [LDH] released as a marker of cell necrosis and gamma-glutamyltransferase [GGT] and N-acetyl-beta-D-glucosaminidase [NAG] present in the homogenate as markers of brush border membrane and lysosome integrity) were measured. Cells were exposed to (i) endotoxin (20 mg/liter), tobramycin (1 mM), or endotoxin plus tobramycin for 48 h, or (ii) endotoxin (100 mg/liter), tobramycin (4 mM), or endotoxin plus tobramycin for 72 h. Endotoxin alone did not alter Pi uptake, but tobramycin inhibited Pi uptake through a decrease in Vmax. The effect was not enhanced by the combination of endotoxin and tobramycin. Endotoxin and tobramycin alone exerted no significant effect upon MGP uptake, but strong inhibition of the Vmax was observed after exposure to a combination of endotoxin plus tobramycin, without alteration of the Km. Endotoxin decreased residual GGT activity in the cell homogenate. Tobramycin increased LDH release in the medium and NAG activity in the homogenate. Endotoxin plus tobramycin resulted in an additive effect upon LDH and NAG activities. In conclusion, by disturbing apical membrane integrity, endotoxin increased tobramycin toxicity in vitro in the absence of serum hormonal mediator.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1673835      PMCID: PMC245004          DOI: 10.1128/AAC.35.2.351

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Adaptation of phosphate transport in phosphate-deprived LLC-PK1 cells.

Authors:  J Caverzasio; C D Brown; J Biber; J P Bonjour; H Murer
Journal:  Am J Physiol       Date:  1985-01

3.  Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis.

Authors:  J L Shenep; R P Barton; K A Mogan
Journal:  J Infect Dis       Date:  1985-06       Impact factor: 5.226

4.  Endotoxin increases the nephrotoxic potential of gentamicin and vancomycin plus gentamicin.

Authors:  M Ngeleka; D Beauchamp; D Tardif; P Auclair; P Gourde; M G Bergeron
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

5.  Influence of endotoxin on the intrarenal distribution of gentamicin, netilmicin, tobramycin, amikacin, and cephalothin.

Authors:  M G Bergeron; Y Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

6.  Inhibition of renal Na+, K+-adenosine triphosphatase by gentamicin.

Authors:  P D Williams; M E Trimble; L Crespo; P D Holohan; J C Freedman; C R Ross
Journal:  J Pharmacol Exp Ther       Date:  1984-11       Impact factor: 4.030

7.  Gentamicin-induced alterations in pig kidney epithelial (LLC-PK1) cells in culture.

Authors:  D W Schwertz; J I Kreisberg; M A Venkatachalam
Journal:  J Pharmacol Exp Ther       Date:  1986-01       Impact factor: 4.030

8.  Lipopolysaccharide and phorbol esters induce differentiation but have opposite effects on phosphatidylinositol turnover and Ca2+ mobilization in 70Z/3 pre-B lymphocytes.

Authors:  P M Rosoff; L C Cantley
Journal:  J Biol Chem       Date:  1985-08-05       Impact factor: 5.157

9.  Augmentation of antibiotic nephrotoxicity by endotoxemia in the rabbit.

Authors:  B M Tune; C Y Hsu
Journal:  J Pharmacol Exp Ther       Date:  1985-08       Impact factor: 4.030

10.  Increased nephrotoxicity of gentamicin in pyelonephritic rats.

Authors:  D Beauchamp; A Poirier; M G Bergeron
Journal:  Kidney Int       Date:  1985-08       Impact factor: 10.612

View more
  6 in total

Review 1.  Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis.

Authors:  A C Cremieux; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

2.  Association of nitric oxide production by kidney proximal tubular cells in response to lipopolysaccharide and cytokines with cellular damage.

Authors:  A F Kaboré; M Denis; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

3.  Increased renal uptake of gentamicin in endotoxemic rats receiving concomitant thromboxane A2 antagonist therapy.

Authors:  M Tardif; Y Bergeron; D Beauchamp; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

4.  Efficacy of temafloxacin in experimental Streptococcus adjacens endocarditis and autoradiographic diffusion pattern of [14C]temafloxacin in cardiac vegetations.

Authors:  A C Cremieux; A Saleh-Mghir; J M Vallois; B Maziere; M Muffat-Joly; C Devine; A Bouvet; J J Pocidalo; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

5.  Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci.

Authors:  J M Entenza; M Blatter; M P Glauser; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

6.  Detecting early kidney damage in horses with colic by measuring matrix metalloproteinase -9 and -2, other enzymes, urinary glucose and total proteins.

Authors:  Bela M Arosalo; Marja Raekallio; Minna Rajamäki; Elina Holopainen; Tuulia Kastevaara; Hanna Salonen; Satu Sankari
Journal:  Acta Vet Scand       Date:  2007-01-23       Impact factor: 1.695

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.